Summary
- Current Price
- As of today, MAZE price is $44.76, down -3.70% in the most recent trading session on
- Current Price All-Time High
- MAZE price is currently -9.12% below its historical high of $49.25 set on
- Market Cap
- MAZE current market cap is $2B, up +314.31% over the past 365 days
- PE Ratio
- MAZE PE ratio is unknown
- Revenue
- MAZE current annual revenue is $167.50M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for MAZE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Maze Therapeutics, Inc. |
| Ticker | NASDAQ: MAZE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | mazetx.com |
| Employees | 125 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $44.76 | |
| Price, 1D Change | -3.70% | |
| $2B | ||
| - | ||
| - | ||
| 0.96 | ||
| $168M | ||
| Revenue, 1Y Change | +100.00% | |
| $0.08 | ||
| EPS, 1Y Change | +103.39% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.08 | ||
| EPS Estimate | -$3.07 | |
| EPS Est. Change | -4,045.50% | |
| $167.50M | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $44.76 | |
| Price Target | - | $50.00 |
| Price Tgt. Change | - | +11.71% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$20.10 | $0.08 | +100.39% | |
| -$3.07 | N/A | -4,045.50% | |
| -$3.15 | N/A | -4,143.70% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $125.63M | $167.50M | +33.33% | |
| - | N/A | - | |
| $1.33M | N/A | -99.20% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $44.76 | |
| $27.45 | ||
| SMA 200 vs Price | -38.68% | |
| $43.75 | ||
| SMA 50 vs Price | -2.27% | |
| 0.96 | ||
| $2.73 | ||
| 54.25 | ||
| 45.97% | ||
| 96.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $167.50M | ||
| $0.08 | ||
| $164.20M | ||
| 98.03% | ||
| $57.59M | ||
| 34.38% | ||
| $18.38M | ||
| 10.97% | ||
| $60.88M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.14 | ||
| 9.76 | ||
| 9.76 | ||
| - | ||
| - | ||
| 29.92 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.68 | ||
| -13.60 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$311.18M | ||
| $196.81M | ||
| $240.54M | ||
| $201.67M | ||
| $43.64M | ||
| $20.67M | ||
| $26.63M | ||
| $4.63M | ||
| $1.94M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $109.91M | ||
| $109.91M | ||
| $3.30M | ||
| $26.42M | ||
| $3.30M | ||
| $0.00 | ||
| $1.17M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $75.95M | ||
| -$1.15M | ||
| $92.85M | ||
| $1.15M | ||
| $74.81M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| Wells Fargo | ||
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with MAZE
FAQ
What is the ticker symbol for Maze Therapeutics, Inc.?
The ticker symbol for Maze Therapeutics, Inc. is NASDAQ:MAZE
Does Maze Therapeutics, Inc. pay dividends?
No, Maze Therapeutics, Inc. does not pay dividends
What sector is Maze Therapeutics, Inc. in?
Maze Therapeutics, Inc. is in the Healthcare sector
What industry is Maze Therapeutics, Inc. in?
Maze Therapeutics, Inc. is in the Biotechnology industry
What country is Maze Therapeutics, Inc. based in?
Maze Therapeutics, Inc. is headquartered in United States
When did Maze Therapeutics, Inc. go public?
Maze Therapeutics, Inc. initial public offering (IPO) was on January 31, 2025
Is Maze Therapeutics, Inc. in the S&P 500?
No, Maze Therapeutics, Inc. is not included in the S&P 500 index
Is Maze Therapeutics, Inc. in the NASDAQ 100?
No, Maze Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Maze Therapeutics, Inc. in the Dow Jones?
No, Maze Therapeutics, Inc. is not included in the Dow Jones index
When was Maze Therapeutics, Inc. last earnings report?
Maze Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Maze Therapeutics, Inc. report earnings?
The next expected earnings date for Maze Therapeutics, Inc. is March 5, 2026
Data Sources & References
- MAZE Official Website www.mazetx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1842295/000119312525269689/0001193125-25-269689-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1842295/000095017025047208/0000950170-25-047208-index.htm
- MAZE Profile on Yahoo Finance finance.yahoo.com/quote/MAZE
- MAZE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/maze